Literature DB >> 11191052

Ultrasound for the visualization and quantification of tumor microcirculation.

F S Foster1, P N Burns, D H Simpson, S R Wilson, D A Christopher, D E Goertz.   

Abstract

Advances in ultrasound based methods for the non-invasive assessment of the tumor microcirculation are described. Two new ultrasound approaches are highlighted. The first method relies on commercially available ultrasound contrast agents in combination with specialized nonlinear imaging sequences. Nonlinear scattering by microbubble contrast agents provides a unique intravascular signature that can be distinguished from the echoes caused by surrounding tissues. Through destruction-reperfusion experiments it is possible to use microbubble contrast agents as a tracer revealing the kinetics of tumor blood flow. The second ultrasound method for examining the microcirculation involves the use of much higher frequencies. At frequencies on the order of 50 MHz, Doppler processing allows the direct assessment of flow dynamics in realtime in arterioles as small as 15 microm. Three dimensional Doppler maps of flow patterning are presented. The strengths and weaknesses of these new methods are discussed and the potential for their use in preclinical animal drug studies, clinical drug trials, and prognostic studies is described.

Entities:  

Mesh:

Year:  2000        PMID: 11191052     DOI: 10.1023/a:1026541510549

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  23 in total

Review 1.  [Ultrasound contrast agents].

Authors:  T Albrecht; J Hohmann
Journal:  Radiologe       Date:  2003-10       Impact factor: 0.635

2.  Tumor radiation response enhancement by acoustical stimulation of the vasculature.

Authors:  Gregory J Czarnota; Raffi Karshafian; Peter N Burns; Shun Wong; Azza Al Mahrouki; Justin W Lee; Amanda Caissie; William Tran; Christina Kim; Melissa Furukawa; Emily Wong; Anoja Giles
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

3.  The role of acoustofluidics in targeted drug delivery.

Authors:  Nilanjana Bose; Xunli Zhang; Tapas K Maiti; Suman Chakraborty
Journal:  Biomicrofluidics       Date:  2015-08-20       Impact factor: 2.800

4.  High-frequency ultrasound Doppler system for biomedical applications with a 30-MHz linear array.

Authors:  Xiaochen Xu; Lei Sun; Jonathan M Cannata; Jesse T Yen; K Kirk Shung
Journal:  Ultrasound Med Biol       Date:  2007-11-12       Impact factor: 2.998

5.  Cavitation threshold of microbubbles in gel tunnels by focused ultrasound.

Authors:  Elisabetta Sassaroli; Kullervo Hynynen
Journal:  Ultrasound Med Biol       Date:  2007-06-27       Impact factor: 2.998

6.  High-resolution, high-contrast ultrasound imaging using a prototype dual-frequency transducer: in vitro and in vivo studies.

Authors:  Ryan Gessner; Marc Lukacs; Mike Lee; Emmanuel Cherin; F Stuart Foster; Paul A Dayton
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2010-08       Impact factor: 2.725

7.  Effect of microbubble size on fundamental mode high frequency ultrasound imaging in mice.

Authors:  Shashank Sirsi; Jameel Feshitan; James Kwan; Shunichi Homma; Mark Borden
Journal:  Ultrasound Med Biol       Date:  2010-05-05       Impact factor: 2.998

Review 8.  Nanoparticle delivery enhancement with acoustically activated microbubbles.

Authors:  Lee B Mullin; Linsey C Phillips; Paul A Dayton
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-01       Impact factor: 2.725

9.  Influence of shell properties on high-frequency ultrasound imaging and drug delivery using polymer-shelled microbubbles.

Authors:  Parag V Chitnis; Sujeethraj Koppolu; Jonathan Mamou; Ceciel Chlon; Jeffrey A Ketterling
Journal:  IEEE Trans Ultrason Ferroelectr Freq Control       Date:  2013-01       Impact factor: 2.725

10.  Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study.

Authors:  Matias Jurado; Rosendo Galván; Rafael Martinez-Monge; Jesús Mazaira; Juan Luis Alcazar
Journal:  World J Surg Oncol       Date:  2008-11-25       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.